The import of high-tech pharmaceutical products to France has shown significant growth from 2013 to 2023, with the value reaching 19.76 Billion Euros in 2023. The year-on-year variation indicates fluctuating growth rates with notable peaks in 2014 (24.01%) and 2020 (17.15%). More recent figures show a deceleration in growth with a 3.25% increase in 2023. Over the past five years, the Compound Annual Growth Rate (CAGR) stood at 9.03%, demonstrating a strong upward trend.
Forecasts suggest a steady increase in imports, reaching an estimated 22.78 Billion Euros by 2028. The forecasted 5-year CAGR is projected at 2.26%, with an overall growth rate of 11.8% over the same period, indicating a more moderate yet consistent expansion.
Future trends to watch for include the impact of digital health advancements, biopharmaceutical innovation, and regulatory changes on the high-tech pharmaceutical import market. Emerging markets and increased demand for personalized medicine are also likely to influence future growth dynamics.
